Dyne Therapeutics
193 hedge funds and large institutions have $3.92B invested in Dyne Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 79 increasing their positions, 46 reducing their positions, and 21 closing their positions.
527% more call options, than puts
Call options by funds: $6.11M | Put options by funds: $973K
124% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 21
72% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 46
45% more capital invested
Capital invested by funds: $2.71B → $3.92B (+$1.21B)
40% more funds holding in top 10
Funds holding in top 10: 10 → 14 (+4)
14% more funds holding
Funds holding: 169 → 193 (+24)
3.01% less ownership
Funds ownership: 116.41% → 113.4% (-3%)
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$95.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$61M |
| 3 |
Holocene Advisors
New York
|
+$60.3M |
| 4 |
BlackRock
New York
|
+$58M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$56.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIA
201
Concurrent Investment Advisors
Tampa,
Florida
| – | -$573K | -20,200 | Closed |
|
|
GS
202
GTS Securities
New York
| – | -$528K | -18,613 | Closed |
|
203
Millennium Management
New York
| – | -$511K | -18,011 | Closed |
|
204
LPL Financial
San Diego,
California
| – | -$429K | -15,114 | Closed |
|
|
N
205
Natixis
Paris,
France
| – | -$397K | -14,000 | Closed |
|
|
RAM
206
Redmond Asset Management
Henrico,
Virginia
| – | -$355K | -12,500 | Closed |
|
|
DM
207
Deerfield Management
New York
| – | -$225K | -7,940 | Closed |
|
|
MLICM
208
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$89.1K | -3,137 | Closed |
|
209
Belvedere Trading
Chicago,
Illinois
| – | -$51.3K | -1,807 | Closed |
|
210
Allspring Global Investments
Charlotte,
North Carolina
| – | -$34.4K | -1,210 | Closed |
|
|
TC
211
Truvestments Capital
Sarasota,
Florida
| – | -$13.2K | -464 | Closed |
|
|
ACM
212
ADAR1 Capital Management
Austin,
Texas
| – | -$8.43K | -297 | Closed |
|
|
AWM
213
Avior Wealth Management
Omaha,
Nebraska
| – | -$255 | -9 | Closed |
|
214
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$232 | +8 | +400% |
|
DYN Hedge Fund Activity: Q2 2024 in Review
193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2024, worth a combined $3.92B — up 45% from $2.71B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new DYN positions and 21 closed out — a net gain of 26 holders — while 79 added to existing stakes and 46 trimmed.
The largest buyer was RTW Investments, adding an estimated $95.8M. The largest seller was MPM Asset Management, cutting an estimated $54.9M.
- 193 institutional investors held Dyne Therapeutics (DYN) as of Q2 2024, up from 169 in Q1 2024.
- Funds reported $3.92B of Dyne Therapeutics stock for Q2 2024, up 45% quarter-over-quarter.
- 47 funds opened new Dyne Therapeutics positions in Q2 2024 and 21 closed out, a net change of +26 holders.
- The largest Dyne Therapeutics buyer in Q2 2024 was RTW Investments, an estimated $95.8M added.
- The largest Dyne Therapeutics seller in Q2 2024 was MPM Asset Management, an estimated $54.9M sold.
Based on aggregated 13F filings for Q2 2024.